Epidemiology in gestational diabetes mellitus
This presentation is the property of its rightful owner.
Sponsored Links
1 / 19

EPIDEMIOLOGY IN GESTATIONAL DIABETES MELLITUS PowerPoint PPT Presentation


  • 146 Views
  • Uploaded on
  • Presentation posted in: General

EPIDEMIOLOGY IN GESTATIONAL DIABETES MELLITUS. Methodology. Dr. Nam-Han Cho Associate Professor of Preventive Medicine Director of Center for Clinical Epidemiology Ajou University School of Medicine Suwon, Korea. GESTATIONAL DIABETES MELLITUS.

Download Presentation

EPIDEMIOLOGY IN GESTATIONAL DIABETES MELLITUS

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Epidemiology in gestational diabetes mellitus

EPIDEMIOLOGY IN GESTATIONAL DIABETES MELLITUS

Methodology

Dr. Nam-Han Cho

Associate Professor of Preventive Medicine

Director of Center for Clinical Epidemiology

Ajou University School of Medicine

Suwon, Korea


Gestational diabetes mellitus

GESTATIONAL DIABETES MELLITUS

Gestational Diabetes Mellitus(GDM), defined as carbohydrate intolerance with onset or first recognition during pregnancy:

  • Occurs in approximately 2 to 5% of all pregnancies, with marked worldwide variations reported;

  • Is associated with an increased risk of fetal macro- somia, as well as perinatal morbidity and mortality;

  • Is linked with future developments of diabetes mellitus in women post-pregnancy.


Methodological inconsistencies in epidemiological studies of gdm

SCREENING

  • Glucose loads range from 50g to 100g

  • Threshold values range from 125 mg/dl to 150 mg/dl

  • Glucose loads range from 50g to 100g

  • Two and Three hour tests are used

  • Differences in diagnostic procedures and values

METHODOLOGICAL INCONSISTENCIES IN EPIDEMIOLOGICAL STUDIES OF GDM

DIAGNOSTIC OGTT


Difference in screening threshold values and ethnic differences in the rate of gdm

DIFFERENCE IN SCREENING THRESHOLD VALUES AND ETHNIC DIFFERENCES IN THE RATE OF GDM

Author SiteThreshold for OGTT Race Prevalence*

Green S. F >150mg/dlWhite 1.6

Black 1.7

Hispanic 4.2

Berkowitz New York  135mg/dl White 2.3

Black 3.7

Hispanic 4.1

Dooley Chicago  130mg/dl White 2.7

Black 3.3

Hispanic 4.4

* 50g-1hr, 100g-3 hr OGTT


Research area

RESEARCH AREA

Maternal

  • High Risk forPIH

  • High Risk forDM

Offspring

  • High Risk for birthcomplications

  • High Risk forObesity

  • High Risk forIGT/DM

  • Potential Risk for the futureHypertension


Risk factors for dm after gdm

Risk Factors for DM after GDM

  • Impaired ß-cell function

  • Higher PIBW

  • Family history (30% M, 11% F)


Overview minor adverse health effects for offspring

Overview:Minor adverse health effects for offspring

NormalGDMDMP

Birth Wt (g)3303±643649±51 3849±72 <0.01

Macrosomia(%)83647<0.01

C-S 51014<0.01

Hypoglycemia 22852<0.01

Hypocalcemia 0 4 7<0.01

Hyperbilirubinemia152321<0.01

Polycythemia 0 711<0.01

Cord C-Pep 1.18±0.1 2.07±0.12 2.98±0.22 <0.01

Cord Glu 100±3.6 103±2.9 114±5.5 <0.01


Macrosomia

MACROSOMIA

GDMNon-diabetic p-value

Birth Wt (g)3512±711 3333±479 <0.05

LGA 40.4% 13.7% <0.001

Macrosomia(%) 32.0% 11.0% <0.01


Overview major adverse health effects for offspring

Overview:Major adverse health effects for offspring

NormalDM

CNS6.4%18.4%

Congenital heart disease7.5%21.0%

Respiratory disease2.9%7.9%

Intestinal atresia0.6%2.6%

Anal atresia1.0%2.6%

Renal & Urinary defect3.1%11.8%

Upper limb deficiences2.3%3.9%

Lower limb deficiences1.2%6.6%

Upper + Lower spine0.1%6.6%

Caudal dysgenesis0.1%5.3%


Neonatal complications

NEONATAL COMPLICATIONS

DMGDMNormal p-value

T. hypoglycemia(%) 5228 3<0.01

P. hypoglycemia(%) 6 2 0<0.01

Hypocalcemia(%) 5 5 0<0.01

Hyperbilirubinemia(%) 212315<0.01

Trans tachypnea(%) 5 2 0<0.01

Polycythemia(%) 11 7 0<0.01

RDS(%) 5 2 0<0.01IUGR(%) 2 1 0<0.05


Ongoing gdm epidemiologic studies prevalence study

ONGOING GDM EPIDEMIOLOGIC STUDIES :Prevalence Study

Study Sites

  • Chicago

  • Cheil Samsung

  • Ajou University Hospital


Methodology

METHODOLOGY

SCREENING

50g / 1 hr at 24-28 weeks gestation

130 mg/dl requires 100g, 3 hr OGTT

DIAGNOSTIC OGTT

Fasting (105 mg/dl)

1 hour (190 mg/dl)

2 hour (165 mg/dl)

3 hour (145 mg/dl)


Ongoing gdm epidemiologic studies prevalence study1

ONGOING GDM EPIDEMIOLOGIC STUDIES :Prevalence Study

Prevalence of GDM

SITE RACE PREVALENCE

ChicagoWhite2.7%

Black3.3%

Hispanic4.4%

Korean American4.5 -13.6%

SeoulKorean2.2%

SuwonKorean5.0%


Longitudinal study of gdm

Ajou University Hospital

Samsung Cheil General

Cha Hospital

Il-Sin Christian Hospital

Anthropometric

Demographic

75gm-2 hr OGTT

Stress

Diet

BIP

Lipid Profile

LONGITUDINAL STUDY OF GDM

Site and Measurements


Longitudinal study of gdm1

Skin fold caliper

Questionnaire

BIP (GIF-891DX)

Insulin assay

Inter-Variation (0.97-0.98)

Intra-Variation (cv=0.23-0.38%)

Sampling Tube - Device

LONGITUDINAL STUDY OF GDM

Standardization


Longitudinal study of gdm2

GDM screening 

Maternal follow-up 

Offspring follow-up

LONGITUDINAL STUDY OF GDM

Projects


Success to the project

SUCCESS TO THE PROJECT

Dept. of Prev. Med.

Center for Clinical

Epidemiology

Dept. of Ob-Gyn

Dept. of Endocr.


  • Login